Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of ...

Sarepta Therapeutics shares plunged 36% after the company reported a second case of acute liver failure resulting in death from taking Elevidys, which is a gene therapy for patients with Duchenne ...

Just me, testing ideas. This is where I take information that has helped me grow and improve, consolidate it, and present it ...

The president is seeking to open up national monuments for drilling. But more land isn’t what oil companies need right now.